Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes

Nick S R Lan; Regina S Y Hong; Christopher Ryan; Alicia J Jenkins; P Gerry Fegan

doi:10.1016/j.pcd.2023.07.005

Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes

Nick S R Lan
, Regina S Y Hong
, Christopher Ryan
, Alicia J Jenkins
, P Gerry Fegan

Internal Medicine

Research output: Contribution to journal › Article › peer-review

4 Citations (Web of Science)

Abstract

Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.

Original language	English
Pages (from-to)	526-528
Number of pages	3
Journal	Primary care diabetes
Volume	17
Issue number	5
DOIs	https://doi.org/10.1016/j.pcd.2023.07.005
Publication status	Published - Oct 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.pcd.2023.07.005

Cite this

@article{afaa935f7cdd458189461ad44345b43e,

title = "Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes",

abstract = "Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.",

author = "Lan, \{Nick S R\} and Hong, \{Regina S Y\} and Christopher Ryan and Jenkins, \{Alicia J\} and Fegan, \{P Gerry\}",

year = "2023",

month = oct,

doi = "10.1016/j.pcd.2023.07.005",

language = "English",

volume = "17",

pages = "526--528",

journal = "Primary care diabetes",

issn = "1878-0210",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes

AU - Lan, Nick S R

AU - Hong, Regina S Y

AU - Ryan, Christopher

AU - Jenkins, Alicia J

AU - Fegan, P Gerry

PY - 2023/10

Y1 - 2023/10

N2 - Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.

AB - Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.

UR - https://www.scopus.com/pages/publications/85166653017

U2 - 10.1016/j.pcd.2023.07.005

DO - 10.1016/j.pcd.2023.07.005

M3 - Article

C2 - 37532667

SN - 1878-0210

VL - 17

SP - 526

EP - 528

JO - Primary care diabetes

JF - Primary care diabetes

IS - 5

ER -

Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this